Humana (HUM) CEO James Rechtin Receives 35,633-Share Award

What Happened

• James A. Rechtin, President & CEO of Humana Inc. (HUM), received an award of 35,633 shares on 2026-05-01. The grant is reported at $0.00 per share (code A) and represents restricted stock units (RSUs)/contingent rights to receive shares under Humana’s stock incentive plans. This is a grant/award—not a purchase or sale—so no immediate cash transaction or proceeds were reported.

Key Details

• Transaction date: 2026-05-01; Form 4 filed: 2026-05-05 (filing appears timely).
• Transaction type/code: Award/Grant (A); price reported: $0.00.
• Shares granted: 35,633 restricted stock units (contingent right to receive one share per RSU).
• Shares owned after transaction: Not specified in the filing.
• Relevant footnotes:
  • F4/F5/F6: These awards are RSUs under Humana’s 2019 Amended & Restated Stock Incentive Plan (and 2026 Stock Incentive Plan); RSUs are contingent rights exempt under Rule 16b-3(d)(1)&(3).
  • F5/F6 reference prior RSU grants and vesting schedules (e.g., earlier 1/8/2024 grants vesting in three annual installments).
  • F1: Some shares are held in revocable trusts for the reporting person and spouse, with the reporting person as a trustee.
• No tax-withholding sale or immediate cashless disposition is indicated in this filing.

Context

• RSUs are a common form of executive compensation: they represent the right to receive shares in the future, typically subject to vesting conditions and therefore do not reflect an immediate purchase or sale of stock.
• Because this is an award, it is not an indicator of immediate insider selling or buying—investors should watch vesting schedules and future filings for when shares are delivered or sold.